NEWS + MEDIA
> Press Releases
> Archive
> Presentations
and Publications
> Calendar
of Events
> Media
Coverage
Press Releases
Archive
12/10/2012
Senesco Provides Summary of SNS01-T Progress in Phase 1b/2a Trial Interim Results presented at ASH
11/28/2012
Senesco to Present on SNS01-T at 54th American Society of Hematology Annual Meeting
11/26/2012
Senesco Technologies Provides Corporate Update
11/21/2012
Senesco Announces Quotation of Common Stock on the Over-the-Counter Securities Market
11/19/2012
Senesco Announces Delisting of Common Stock from NYSE MKT LLC and Pending Transfer to an Over-the-Counter Securities Market
11/15/2012
Senesco Technologies Reports First Quarter Fiscal 2013 Financial Results
11/7/2012
Senesco Announces Expansion of Phase 1b/2a Study to Include Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma First DLBCL Patient Dosed in Study
9/18/2012
Senesco Technologies Reports Fiscal Year 2012 Financial Results
9/18/2012
Senesco Technologies Reports Fiscal Year 2012 Financial Results
9/13/2012
Senesco Announces First Dose of SNS01-T in Cohort 2 of Phase 1b/2a Study in Multiple Myeloma Trial
Next Page
Disclaimer